Cargando…

Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule)

BACKGROUND: Diabetic nephropathy is an emergent issue in China with increase in patients with type II diabetes. There are several successful Chinese herbal products for the treatment of patients with diabetic nephropathy in China. However, the mechanisms mediating the biological activity of these pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Jingai, Wei, Hongkun, Sun, Yanyan, Zhang, Xiaodong, Liu, Wenyuan, Chang, Qintao, Wang, Ruihua, Gong, Yuewen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637235/ https://www.ncbi.nlm.nih.gov/pubmed/23560927 http://dx.doi.org/10.1186/1472-6882-13-76

Ejemplares similares

Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
por: Zhang, Ziyuan, et al.
Publicado: (2022)

Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022)

Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
por: Hu, Yaling, et al.
Publicado: (2022)

Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy
por: Liu, Yuxiang, et al.
Publicado: (2021)

A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease
por: Zhou, Xue-Feng, et al.
Publicado: (2021)

Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study
por: Zeng, Lingfeng, et al.
Publicado: (2022)

Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-β/Smad3 Signaling
por: Zhao, Ting Ting, et al.
Publicado: (2014)

Podocalyxin in Normal Tissue and Epithelial Cancer
por: Le Tran, Ngoc, et al.
Publicado: (2021)

Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)
por: Zhang, Haojun, et al.
Publicado: (2011)

Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial
por: Mao, Wei, et al.
Publicado: (2021)

Role of podocalyxin in astrocytoma: Clinicopathological and in vitro evidence
por: HUANG, TIANXIANG, et al.
Publicado: (2013)

Podocalyxin regulates pronephric glomerular development in zebrafish
por: Ichimura, Koichiro, et al.
Publicado: (2013)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
por: Hara, M., et al.
Publicado: (2012)

Effects and Mechanism of Bufei Yishen Formula in a Rat Chronic Obstructive Pulmonary Disease Model
por: Li, Jiansheng, et al.
Publicado: (2014)

Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation
por: Sun, Xian, et al.
Publicado: (2022)

Distinct Functional Requirements for Podocalyxin in Immature and Mature Podocytes Reveal Mechanisms of Human Kidney Disease
por: Refaeli, Ido, et al.
Publicado: (2020)

Bupi Yishen formula attenuates kidney injury in 5/6 nephrectomized rats via the tryptophan-kynurenic acid-aryl hydrocarbon receptor pathway
por: Mo, Yenan, et al.
Publicado: (2021)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy
por: Imaizumi, Takahiro, et al.
Publicado: (2016)

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
por: Zhang, Difei, et al.
Publicado: (2021)

Antidiabetic, antihyperlipidemic activities and herb–drug interaction of a polyherbal formulation in streptozotocin induced diabetic rats
por: Choudhari, Vishnu P., et al.
Publicado: (2017)

Effects of Yishen Pinggan Recipe on Renal Protection and NF-κB Signaling Pathway in Spontaneously Hypertensive Rats
por: Luo, Guodong, et al.
Publicado: (2016)

Diminished Thrombogenic Responses by Deletion of the Podocalyxin Gene in Mouse Megakaryocytes
por: Pericacho, Miguel, et al.
Publicado: (2011)

Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition
por: Meng, Xiaobo, et al.
Publicado: (2011)

Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide
por: WU, HAO, et al.
Publicado: (2013)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes
por: Trimarchi, Hernán, et al.
Publicado: (2018)

Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
por: Zhai, Limin, et al.
Publicado: (2015)

Decrease of Klotho in the Kidney of Streptozotocin-Induced Diabetic Rats
por: Cheng, Meng-Fu, et al.
Publicado: (2010)

Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
por: Li, Jiansheng, et al.
Publicado: (2015)

Yishen Xiezhuo formula ameliorates the development of cisplatin-induced acute kidney injury by attenuating renal tubular epithelial cell senescence
por: Zhang, Qiaoying, et al.
Publicado: (2022)

Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats
por: Tian, Yange, et al.
Publicado: (2015)

The pharmacology of Chinese herbs /
por: Huang, K. C. (Kee Chang), 1917-
Publicado: (1999)

Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell
Publicado: (1984)

The cell surface mucin podocalyxin regulates collective breast tumor budding
por: Graves, Marcia L., et al.
Publicado: (2016)

Determination of critical epitope of PcMab-47 against human podocalyxin
por: Itai, Shunsuke, et al.
Publicado: (2018)

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry
por: Ogasawara, Satoshi, et al.
Publicado: (2017)

Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function
por: Román-Fernández, Alvaro, et al.
Publicado: (2023)

The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast
por: Li, Yangyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6vm7eu1lpb0ath3r09n4pqn79b